Patrick J. Christmas Regenxbio Inc. (RGNX) insider trading activity

Patrick J. Christmas is Chief Legal Officer of REGENXBIO Inc.. Currently has a direct ownership of 81,144 shares of RGNX, which is worth approximately $884,469. The most recent transaction as insider was on Jan 02, 2024, when has been sold 7,893 shares (Common Stock) at a price of $17.95 per share, resulting in proceeds of $141,679. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.1K

0% 3M change

284.62% 12M change

Total Value Held $884,469

Patrick J. Christmas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2024	SELL Payment of exercise price or tax liability	$141,679 $17.95 p/Share	7,893 Reduced 8.86%	81,144 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	34,615 Added 23.02%	115,759 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$41,799 $22.68 p/Share	1,843 Reduced 8.03%	21,097 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	67,940 Added 43.28%	89,037 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	7,900 Added 25.62%	22,940 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$43,556 $32.7 p/Share	1,332 Reduced 8.14%	15,040 Common Stock
Feb 12 2021	SELL Open market or private sale	$230,725 $49.08 p/Share	4,701 Reduced 22.31%	16,372 Common Stock

Feb 12 2021	BUY Exercise of conversion of derivative security	$56,882 $12.1 p/Share	4,701 Added 18.24%	21,073 Common Stock
Feb 08 2021	SELL Open market or private sale	$63,843 $49.11 p/Share	1,300 Reduced 7.36%	16,372 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$15,730 $12.1 p/Share	1,300 Added 6.85%	17,672 Common Stock
Feb 02 2021	SELL Open market or private sale	$449,500 $44.95 p/Share	10,000 Reduced 37.92%	16,372 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$121,000 $12.1 p/Share	10,000 Added 27.49%	26,372 Common Stock
Jan 12 2021	SELL Open market or private sale	$67,729 $49.15 p/Share	1,378 Reduced 7.76%	16,372 Common Stock
Jan 12 2021	BUY Exercise of conversion of derivative security	$26,871 $19.5 p/Share	1,378 Added 7.2%	17,750 Common Stock
Jan 11 2021	SELL Open market or private sale	$496,788 $49.08 p/Share	10,122 Reduced 38.2%	16,372 Common Stock
Jan 11 2021	BUY Exercise of conversion of derivative security	$159,928 $15.8 p/Share	10,122 Added 27.64%	26,494 Common Stock
Jan 08 2021	SELL Open market or private sale	$473,300 $47.33 p/Share	10,000 Reduced 37.92%	16,372 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	$121,000 $12.1 p/Share	10,000 Added 27.49%	26,372 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	13,800 Added 45.74%	16,372 Common Stock

PJC

Patrick J. Christmas

Chief Legal Officer

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Value

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX

Account